Skip to main content
Veterinary Medicines

PROGRESSIS injekčná emulzia pre ošípané

Authorised
  • Porcine reproductive and respiratory syndrome virus, type 1, strain P120, Inactivated

Product identification

Medicine name:
PROGRESSIS injekčná emulzia pre ošípané
Active substance:
  • Porcine reproductive and respiratory syndrome virus, type 1, strain P120, Inactivated
Target species:
  • Pig (sow for reproduction)
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Porcine reproductive and respiratory syndrome virus, type 1, strain P120, Inactivated
    2.50
    log10 fluorescent assay infectious dose 50%
    /
    2.00
    millilitre(s)
Pharmaceutical form:
  • Emulsion for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Pig (sow for reproduction)
      • All relevant tissues
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI09AA05
Authorisation status:
  • Valid
Authorised in:
  • Slovakia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Ceva Animal Health Slovakia s.r.o.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health France
  • Ceva-Phylaxia Veterinary Biologicals Co. Ltd.
Responsible authority:
  • Institute For State Control Of Veterinary Biologicals And Medicaments
Authorisation number:
  • 97/011/03-S
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Slovak (PDF)
Published on: 23/05/2023
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."